Firefly Neuroscience, Inc. (AIFF) Income Statement
AIFF 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsAIFF revenue and net income
Where AIFF's revenue goes
2025Each bar shows an amount and its share of revenue. AIFF kept −1,741.0% of revenue as net income.
AIFF profit margins
AIFF growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +957.4% | — | −39.3% | — |
| Gross profit | +1,473.2% | — | −21.8% | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
AIFF quarterly EPS vs estimates
Firefly Neuroscience beat the analyst EPS estimate in 0 of the last 1 quarters. Next report: November 11, 2026.
AIFF income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | $1.1M | $108,000 | $498,000 | $0 | $32,000 | $13.9M |
| Cost of revenue | $497,000 | $67,000 | $0 | $0 | $0 | $11.7M |
| Gross profit | $645,000 | $41,000 | $498,000 | $0 | $32,000 | $2.2M |
| Research & development | $1.5M | $2.0M | $741,000 | $1.3M | $2.9M | — |
| Sales, general & admin | $7.8M | $7.3M | $2.8M | $2.0M | $1.7M | — |
| Total operating expenses | $9.2M | $9.2M | $3.6M | $3.3M | $4.7M | $1.8M |
| Operating income | −$8.6M | −$9.2M | −$3.1M | −$3.3M | −$4.7M | $411,848 |
| Interest income | $89,000 | $0 | — | — | — | — |
| Interest expense | $159,000 | $69,000 | $18,000 | $574,000 | $135,000 | — |
| Income before taxes | −$19.9M | −$10.5M | −$2.6M | −$3.8M | −$4.4M | $413,379 |
| Income taxes | $5,000 | $2,000 | $1,000 | — | — | — |
| Net income | −$19.9M | −$10.5M | −$2.6M | −$3.8M | −$4.4M | $413,379 |
| EBITDA | −$19.5M | −$10.3M | −$2.6M | −$3.2M | −$3.8M | $425,440 |
| EPS (diluted) | −$1.47 | −$2.64 | −$3.30 | −$8.11 | −$2.24 | −$0.38 |
| Gross margin | 56.5% | 38.0% | 100.0% | — | 100.0% | 15.9% |
| Operating margin | −753.5% | −8,500.0% | −618.1% | — | −14,543.8% | 3.0% |
| Net margin | −1,741.0% | −9,685.2% | −522.7% | — | −13,690.6% | 3.0% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $514,000 | $485,000 | $412,000 | $388,000 | $299,000 | $43,000 | $53,000 | $33,000 | $1.9M | $12,000 | $19,000 | $23,000 |
| Cost of revenue | $261,000 | $264,000 | $230,000 | $242,000 | $25,000 | $0 | $59,000 | $1.5M | $1.2M | $1.3M | $0 | $54,000 |
| Gross profit | $253,000 | $221,000 | $182,000 | $146,000 | $274,000 | $43,000 | $53,000 | −$1.4M | $682,695 | $12,000 | $19,000 | $23,000 |
| Research & development | $525,000 | $424,000 | $456,000 | $378,000 | $336,000 | $312,000 | $437,000 | $878,000 | $350,000 | $289,000 | $29,000 | $392,000 |
| Sales, general & admin | $1.7M | $1.8M | $2.0M | $2.3M | $1.6M | $1.8M | $2.2M | $2.0M | $948,356 | $814,000 | $1.6M | $278,000 |
| Total operating expenses | $2.2M | $2.2M | $2.4M | $2.8M | $1.9M | $2.1M | $3.5M | $2.8M | $1.1M | $1.1M | $1.6M | $670,000 |
| Operating income | −$2.0M | −$2.0M | −$2.2M | −$2.7M | −$1.6M | −$2.1M | −$3.4M | −$4.3M | −$382,070 | −$1.1M | −$1.6M | −$647,000 |
| Interest income | $41,000 | $14,000 | $30,000 | $29,000 | $30,000 | $0 | — | $0 | $0 | — | — | — |
| Interest expense | $6,000 | $7,000 | $6,000 | $10,000 | $15,000 | $128,000 | $33,000 | $24,000 | $10,367 | $2,000 | $5,000 | $3,000 |
| Income before taxes | −$2.0M | −$2.0M | −$2.5M | −$2.6M | −$1.8M | −$12.9M | −$3.8M | −$4.3M | −$389,697 | −$1.1M | −$1.1M | −$650,000 |
| Income taxes | — | — | $1,000 | — | $4,000 | — | $2,000 | — | — | — | $1,000 | — |
| Net income | −$2.0M | −$2.0M | −$2.5M | −$2.6M | −$1.8M | −$12.9M | −$3.8M | −$4.3M | −$389,697 | −$1.1M | −$1.1M | −$650,000 |
| EBITDA | −$1.9M | −$2.0M | −$2.5M | −$2.4M | −$1.8M | −$12.8M | −$2.6M | −$4.3M | −$336,994 | −$1.1M | −$1.1M | −$643,500 |
| EPS (diluted) | −$0.10 | — | — | −$0.20 | −$0.14 | −$0.43 | −$0.45 | −$0.61 | −$0.58 | −$1.00 | −$1.16 | −$0.23 |
| Gross margin | 49.2% | 45.6% | 44.2% | 37.6% | 91.6% | 100.0% | 100.0% | −4,360.6% | 35.9% | 100.0% | 100.0% | 100.0% |
| Operating margin | −384.0% | −414.4% | −546.1% | −684.5% | −546.5% | −4,802.3% | −6,483.0% | −12,933.3% | −20.1% | −9,091.7% | −8,247.4% | −2,813.0% |
| Net margin | −386.0% | −413.2% | −601.9% | −680.2% | −613.0% | −30,069.8% | −7,141.5% | −12,997.0% | −20.5% | −9,350.0% | −5,668.4% | −2,826.1% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in AIFF's financial statements (latest annual report filed December 31, 2025); data from EODHD. Sales, general & administrative expenses include sales and marketing.
AIFF financial results
In fiscal year 2025 (ended December 31, 2025), Firefly Neuroscience reported revenue of $1.1 million, up 957.4% from the year before. It had a net loss of $19.9 million, a net profit margin of −1,741.0%. Diluted earnings per share came to −$1.47. Over five years revenue grew at an average rate of −39.3% a year.
See the AIFF stock overview for the latest quote and news, or the AIFF chart for price history and technical indicators.
AIFF income statement FAQ
What is Firefly Neuroscience's annual revenue?
Firefly Neuroscience reported total revenue of $1.1 million for fiscal year 2025, which ended on December 31, 2025. That was up 957.4% from $0.1 million the previous year.
Is Firefly Neuroscience profitable?
No. Firefly Neuroscience reported a net loss of $19.9 million in fiscal 2025, a net profit margin of −1,741.0%; its operating margin was −753.5%.
What is Firefly Neuroscience's gross margin?
Firefly Neuroscience's gross margin was 56.5% in fiscal 2025: for every $100 of revenue, Firefly Neuroscience kept $56 after the direct cost of its products and services.
How much does Firefly Neuroscience spend on research and development?
Firefly Neuroscience spent $1.5 million on research and development in fiscal 2025, 129.8% of revenue.
How fast is Firefly Neuroscience growing?
Revenue grew −39.3% a year on average over the last five fiscal years, from $13.9 million to $1.1 million.
What are Firefly Neuroscience's earnings per share?
Firefly Neuroscience earned $-1.47 per diluted share in fiscal 2025, compared with $-2.64 a year earlier.
When will Firefly Neuroscience report its next earnings?
Firefly Neuroscience is expected to report results for the quarter ending September 30, 2026 on November 11, 2026.
When does Firefly Neuroscience's fiscal year end?
Firefly Neuroscience's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on December 31, 2025.